跳至主要内容
临床试验/IRCT20210622051666N1
IRCT20210622051666N1招募中3 期

Evaluation of oral N-acetylcysteine efficacy versus placebo in prevention of mucositis induced by radiotherapy and chemotherapy agents in children with malignancy A double blind randomized clinical trial

Ahvaz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 18 years(—)
性别
All

入选标准

  • Patients who are 2-18 years old
  • Recipients of radiotherapy and anti-metabolite chemotherapy drugs with a high risk of developing oral mucositis (including Doxorubicin, Methotrexate, FU Etoposide, Cytarabine and Melphalan) and other drugs listed below.
  • Patients with lansky performance scale index above 70%
  • No Cardiovascular disease

排除标准

  • Causes any severe allergic reactions to the drug (such as skin complications, bronchospasm, bronchitis, etc.)
  • Any active gastrointestinal disease
  • Cardiovascular disease

研究者

相似试验

Evaluation of oral N-acetylcysteine efficacy versus... | 临床试验